Kestra Medical Technologies, Ltd.
KMTS
$20.70
$1.115.67%
NASDAQ
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -72.32% | -57.06% | -34.72% | -20.92% | -- |
| Total Depreciation and Amortization | -14.68% | -26.86% | -34.23% | -31.07% | -- |
| Total Amortization of Deferred Charges | 44.19% | 17.33% | 137.24% | 129.51% | -- |
| Total Other Non-Cash Items | 694.88% | 673.48% | 599.00% | 501.85% | -- |
| Change in Net Operating Assets | -199.28% | -2,330.48% | -629.76% | -302.55% | -- |
| Cash from Operations | -26.54% | -30.19% | -24.70% | -6.94% | -- |
| Capital Expenditure | -65.88% | -35.76% | -42.08% | -93.53% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,552.88% | 62.87% | 201.60% | 94.04% | -- |
| Cash from Investing | -91.06% | -35.40% | -40.39% | -93.52% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -100.00% | -100.00% | 37.87% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -145.99% | -148.03% | -155.60% | 375.98% | -- |
| Cash from Financing | 183.25% | 52.12% | 26.89% | 324.91% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 504.02% | 86.09% | 25.80% | 3,503.26% | -- |